Search Results

There are 62418 results for: content related to: Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger

  1. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 10, October 2012, Pages: 1855–1858, Keith Sultan, Burton I. Korelitz, Daniel Present, Seymour Katz, Suzanne Sunday and Iuliana Shapira

    Version of Record online : 12 JAN 2012, DOI: 10.1002/ibd.22866

  2. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

    Inflammatory Bowel Diseases

    Volume 7, Issue 3, August 2001, Pages: 181–189, Dr. Marla C. Dubinsky, Philip V. Hassard, Dr. Ernest G. Seidman, Lori Y. Kam, Maria T. Abreu, Dr. Stephan R. Targan and Eric A. Vasiliauskas

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200108000-00001

  3. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: A retrospective cohort study

    Inflammatory Bowel Diseases

    Volume 14, Issue 1, January 2008, Pages: 13–19, Mark H. Flasar, Tamara Johnson, Mary-Claire Roghmann and Raymond K. Cross

    Version of Record online : 31 OCT 2007, DOI: 10.1002/ibd.20298

  4. TOLERABILITY AND USEFULNESS OF MERCAPTOPURINE IN AZATHIOPRINE-INTOLERANT JAPANESE PATIENTS WITH ULCERATIVE COLITIS

    Digestive Endoscopy

    Volume 22, Issue 4, October 2010, Pages: 289–296, Motoaki Kuriyama, Jun Kato, Hideyuki Suzuki, Mitsuhiro Akita, Sakiko Hiraoka, Hiroyuki Okada and Kazuhide Yamamoto

    Version of Record online : 21 JUL 2010, DOI: 10.1111/j.1443-1661.2010.01009.x

  5. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 10, October 2010, Pages: 1626–1630, Yoshikazu Ohtsuka, Katsuhiro Arai, Yo Aoyagi, Tohru Fujii, Yoko Yamakawa, Kiyotaka Ohtani, Tamaki Ikuse, Yosuke Baba, Eisuke Inage, Takahiro Kudo, Ryuyo Suzuki, Satoru Nagata and Toshiaki Shimizu

    Version of Record online : 14 MAY 2010, DOI: 10.1111/j.1440-1746.2010.06364.x

  6. 5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine

    Inflammatory Bowel Diseases

    Volume 12, Issue 4, April 2006, Pages: 251–257, Scott Hande, Noah Wilson-Rich, Athos Bousvaros, Anna Zholudev, Rie Maurer, Peter Banks, Frederick Makrauer, Sarathchandra Reddy, Robert Burakoff and Sonia Friedman

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000206544.05661.9f

  7. How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice

    Inflammatory Bowel Diseases

    Volume 14, Issue 4, April 2008, Pages: 514–518, Jason S. Yip, Mark Woodward, Maria T. Abreu and Miles P. Sparrow

    Version of Record online : 18 DEC 2007, DOI: 10.1002/ibd.20345

  8. You have free access to this content
    Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine

    British Journal of Clinical Pharmacology

    Volume 66, Issue 4, October 2008, Pages: 517–528, Ahmed F. Hawwa, Jeff S. Millership, Paul S. Collier, Koen Vandenbroeck, Anthony McCarthy, Sid Dempsey, Carole Cairns, John Collins, Colin Rodgers and James C. McElnay

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2125.2008.03248.x

  9. Recent Advances Using Immunomodulators for Inflammatory Bowel Disease

    The Journal of Clinical Pharmacology

    Volume 53, Issue 6, June 2013, Pages: 575–588, Ole Haagen Nielsen, Jacob Tveiten Bjerrum, Hans Herfarth and Gerhard Rogler

    Version of Record online : 13 FEB 2013, DOI: 10.1002/jcph.2

  10. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 15, Issue 4, April 2009, Pages: 589–593, Kevin A. Hommel, Christine M. Davis and Robert N. Baldassano

    Version of Record online : 4 NOV 2008, DOI: 10.1002/ibd.20798

  11. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

    Inflammatory Bowel Diseases

    Volume 9, Issue 4, July 2003, Pages: 237–245, Carlton W. Thomas Jr., Philip W. Lowry, Curtis L. Franklin, Amy L. Weaver, Gennett M. Myhre, Dennis C. Mays, William J. Tremaine, James J. Lipsky and William J. Sandborn

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200307000-00004

  12. You have free access to this content
    6-mercaptopurine transport in human lymphocytes: Correlation with drug-induced cytotoxicity

    Journal of Digestive Diseases

    Volume 13, Issue 2, February 2012, Pages: 82–93, Laurie S. CONKLIN, Carmen CUFFARI, Toshihiko OKAZAKI, Yinglei MIAO, Bahman SAATIAN, Tian-E. CHEN, Ming TSE, Steven R. BRANT and Xuhang LI

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1751-2980.2011.00556.x

  13. Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 11, Issue 2, February 2005, Pages: 126–132, Nils Homann, Ute Klarmann, Klaus Fellermann, Andreas Brüning, Rolf Klingenberg-Noftz, Thomas Witthöft, Eduard F. Stange and Diether Ludwig

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200502000-00005

  14. The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse

    International Journal of Experimental Pathology

    Volume 89, Issue 2, April 2008, Pages: 138–158, Gemma Molyneux, Frances M. Gibson, Christabelle M. Chen, Harpal K. Marway, Sean McKeag, Charles V. J. Mifsud, Andrew M. Pilling, Matthew J. Whayman and John A. Turton

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1365-2613.2008.00575.x

  15. What are the rules when treatment with 6-MP/AZA is started?

    Inflammatory Bowel Diseases

    Volume 14, Issue S2, October 2008, Pages: S262–S263, Burton I. Korelitz

    Version of Record online : 24 SEP 2008, DOI: 10.1002/ibd.20705

  16. You have free access to this content
    Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Nilesh Chande, Petrease H Patton, David J Tsoulis, Benson S Thomas and John K MacDonald

    Published Online : 30 OCT 2015, DOI: 10.1002/14651858.CD000067.pub3

  17. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1608–1616, Glen A. Doherty, Rebecca A. Miksad, Adam S. Cheifetz and Alan C. Moss

    Version of Record online : 8 SEP 2011, DOI: 10.1002/ibd.21904

  18. You have free access to this content
    Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 1, January 2012, Pages: 15–36, L. Chouchana, C. Narjoz, P. Beaune, M.-A. Loriot and X. Roblin

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1365-2036.2011.04905.x

  19. You have free access to this content
    Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 1, January 2012, Pages: 63–73, Liang Ding, Fang-bin Zhang, Hui Liu, Xiang Gao, Hui-chang Bi, Xue-ding Wang, Bai-li Chen, Yu Zhang, Li-zi Zhao, Guo-ping Zhong, Pin-jin Hu, Min-hu Chen and Ming Huang

    Version of Record online : 4 MAR 2011, DOI: 10.1002/ibd.21676

  20. You have free access to this content
    6-Tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine

    Alimentary Pharmacology & Therapeutics

    Volume 21, Issue 7, April 2005, Pages: 829–839, X. Roblin, F. Serre-Debeauvais, J.-M. Phelip, J.-L. Faucheron, G. Hardy, A. Chartier, F. Helluwaert, G. Bessard and B. Bonaz

    Version of Record online : 24 MAR 2005, DOI: 10.1111/j.1365-2036.2005.02419.x